Statin Safety Claims in Lancet Reignite Acrimony

12:51 EDT 22 Sep 2016 | Medscape

The statin review is being cast as more than yearlong effort to set the record straight regarding the safety and efficacy of statin therapy and at the same time "a total whitewash."
Heartwire from Medscape

Original Article: Statin Safety Claims in Lancet Reignite Acrimony


More From BioPortfolio on "Statin Safety Claims in Lancet Reignite Acrimony"

Quick Search

Relevant Topics

Cholesterol is a waxy steroid metabolite found in the cell membranes and transported in the blood plasma. It is an important structural component of mammalian cell membranes, where it is establishes proper membrane permeability and fluidity. Cholesterol ...

Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...